Colgate-Palmolive Company (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twelve analysts that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $98.9167.
A number of equities analysts recently commented on CL shares. UBS Group decreased their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. Morgan Stanley decreased their target price on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday. Citigroup dropped their price target on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday. Barclays raised their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 15th. Finally, Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th.
View Our Latest Report on Colgate-Palmolive
Institutional Trading of Colgate-Palmolive
Colgate-Palmolive Trading Down 0.2%
NYSE:CL opened at $83.33 on Thursday. The stock has a fifty day simple moving average of $89.40 and a 200 day simple moving average of $90.27. The firm has a market capitalization of $67.53 billion, a price-to-earnings ratio of 23.41, a price-to-earnings-growth ratio of 4.31 and a beta of 0.35. Colgate-Palmolive has a 1-year low of $82.40 and a 1-year high of $109.30. The company has a quick ratio of 0.28, a current ratio of 0.43 and a debt-to-equity ratio of 8.96.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 earnings per share. Sell-side analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Investing In Preferred Stock vs. Common Stock
- Analysts Make a Quantum Bet on D-Wave’s Cryogenic Packaging
- Canada Bond Market Holiday: How to Invest and Trade
- Traders Turn Bullish on Housing Stocks Again—3 Leading the Way
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Onsemi’s August Pullback Is a Signal to Buy for Tech Investors
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.